Abstract

Introduction. Usage of aggressive conditions (solvents, high temperature, etc.) in a dosage form manufacturing can lead to a change in the properties of a pharmaceutical substance. Darunavir (D) amorphous and darunavir ethanolate (DE) crystalline both have poor solubility, ability to pseudopolymorphism and are sensitive to high temperatures.Aim. Study the effect of solvents and drying temperature on the physicochemical properties of D and DE substancesMaterials and methods. D (Mylan Laboratories Limited), DE (Mylan Laboratories Limited), D (reference standard) 99,9 % (MSN Pharmachem Private Limited). D and DE weighed quantity was suspended in one of the solvents via magnetic stirrer and was dried via universal oven. Powder X-ray diffraction of dried samples was carried out via automatic powder diffractometer. Using DSC thermal properties of the samples were studied. Crystalline samples were examined using IR spectroscopy. Identification of D and DE was performed by HPLC method.Results and discussion. This article summarizes study results of the investigation of various solvents and drying temperature influence on the physicochemical properties of D and DE are presented. The impact of solvent type and drying temperatures in physicochemical properties of the APIs was studied by X-ray powder diffraction, differential scanning calorimetry, IR spectroscopy and HPLC methods. It was shown, that solvent type and drying temperatures can result in the presence of crystalline D solvates or amorphous D.Conclusion. To obtain the final drug containing as an API amorphous D, which perform better dissolution, one of the enlisted solvents can be used: dichloromethane, chloroform and heptane. In such case the intermediate product drying should be performed at not exceeding the solvent boiling point temperatures. In case of ethanol, methanol, acetone and tetrahydrofuran drying phase can be performed at temperatures, that are higher than melting points of obtained pseudopolymorphs. For the utilization of DE as an API only ethanol usage is efficient and drying temperature should not exceed 73.4 °C.

Highlights

  • Usage of aggressive conditions in a dosage form manufacturing can lead to a change in the properties of a pharmaceutical substance

  • Identification of D and darunavir ethanolate (DE) was performed by HPLC method

  • The impact of solvent type and drying temperatures in physicochemical properties of the APIs was studied by X-ray powder diffraction, differential scanning calorimetry, IR spectroscopy and HPLC methods

Read more

Summary

МАТЕРИАЛЫ И МЕТОДЫ

Дарунавира этанолат, Mylan Laboratories Limited, Индия, серия No 22128670. Дарунавир, Mylan Laboratories Limited, Индия, серия No 3342845. Дарунавира этанолат, Mylan Laboratories Limited, Индия, серия No 22128670. Дарунавир, Mylan Laboratories Limited, Индия, серия No 3342845. В течение 24 часов при температуре на 5 °C ниже температуры кипения растворителя;. В течение 24 часов при температуре на 5 °C выше температуры плавления получаемых псевдополиморфов. Рентгеновскую порошковую дифрактометрию высушенных образцов проводили с использованием автоматического порошкового дифрактометра Ultima IV (Rigaku, Япония) в соответствии с ОФС.1.2.1.1.0011.15 [7]. Методом дифференциальной сканирующей калориметрии (ДСК) на приборе Q20P (TA Instruments, США) изучали термические свойства образцов. Измерения проводили в атмосфере воздуха при скорости нагрева 10 °C/мин. Съемку спектров ИК проводили на программноаппаратном комплексе на основе ИК-Фурье-спектрометра Vertex 70 (Bruker, США) с использованием приставки НПВО (кристалл ZnSe) при следующих условиях: разрешение – 4 см‐1; количество сканов фона/образца – 16.

Результаты изучения образцов методом рентгеновской порошковой дифрактометрии
Результаты изучения образцов методом ДСК
Результаты изучения образцов методом ИК
Результаты изучения образцов методом ВЭЖХ
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call